News & Articles

The collaboration is the first larger scale production run of Apta-1 as a non-GMP material, intended for use in GLP toxicology studies

The test outperforms other molecular tests with a low detection limit of 15 GEC/reaction (250 GEC/ml of sample) and a robust control system

The consortium aims to determine the dynamics, function and potential for therapeutic intervention of the RNA and protein structures of SARS-CoV-2

IgM assay has 95.51% positive predictive value even when disease incidence is only 3%

The new assays are designed to enable turnaround times for next-generation sequencing results of less than 24 hours

Used to empower clinicians to quickly prescribe treatment regimens for multidrug-resistant TB, the test could help fill a critical gap that is jeopardizing global TB targets

Join us on Tuesday, September 1, to learn about why patients are admitted to an intensive care unit and what is available in terms of physiological support, monitoring, and treatments

Enables labs to quickly ramp up testing capacity and generate results faster

Learn about the potential of lateral flow assays in detecting symptomatic and asymptomatic COVID-19 infections

Dr. Jeremy Hirota takes us through the technology behind his translational research program for respiratory health

Nirsevimab is the first potential passive immunisation for infants to demonstrate sustained protection across the entire RSV season with a single dose

In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of disease severity, including Types 1, 2, and 3 SMA

This collaboration will allow Tecan to expand its presence for these product lines and reach a wider customer base across the academic and biotech communities

The high-throughput system enables laboratories to double or even triple their testing capacity

The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings

Crosslinking mass spectrometry (XL-MS) can leverage the PhoX Crosslinker and TIMS/PASEF methods with the large-scale use of accurate collision cross sections

The new reagent kits aim to make whole genome sequencing more accessible and affordable for labs of all sizes

This powerful new solution aims to provide more accurate COVID-19 antibody detection

Join us on Tuesday, August 11, to learn about a novel serological platform used for COVID-19 testing

Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing

Avacta appoints BBI Solutions as manufacturing partner for the rapid SARS-CoV-2 antigen test being developed with Cytiva

Trial supports Abbott's focus on being the best partner for electrophysiologists treating people living with atrial fibrillation

Vanderbilt researchers use high-throughput data collection, analysis, and visualization to help understand synergy in therapeutic antibody cocktails